Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Wuxi Fortune Pharmaceutical Co., Ltd.
483
•Wuxi Fortune Pharmaceutical Co., Ltd.•September 13, 2023

FDA 483 - Wuxi Fortune Pharmaceutical Co., Ltd. - September 13, 2023

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

An FDA inspection of Wuxi Fortune Pharmaceutical Co., Ltd in Wuxi City, China, revealed significant deficiencies in their manufacturing processes. Observations included a lack of qualification for critical manufacturing equipment and systems, and failures to record and justify deviations from written production procedures. Additionally, the firm did not perform identity and quality testing for incoming Active Pharmaceutical Ingredient (API).

Company
Wuxi Fortune Pharmaceutical Co., Ltd.
Inspection Date
September 13, 2023
Product Type
Drugs
Office
Office of Biological Products Operations - Division I
Person
  • Niketa Patel (Consumer Safety Officer/ORA/OMPTO/TOS)
Open in Dashboard

ID · df20d95e-9b02-48b4-a766-693c46f26888

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.